the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Japan’s new justice minister says scrapping death penalty ‘inappropriate’

TOKYO: Japan’s new justice minister Hideki Makihara has said abolishing the death penalty would be “inappropriate” despite the recent acquittal of the world’s longest-serving death row prisoner.

Japan and the United States are the only two G7 countries that still use capital punishment, which has strong public support in Japan where scrapping it is rarely discussed.

But the policy — always carried out by hanging in Japan — is also criticised for the “cruel” way it is carried out, with prisoners often informed of their impending death in the early morning just a few hours before it happens.

“It would be inappropriate to abolish” the death penalty as “heinous crimes continue to occur”, Makihara told reporters on Wednesday after being nominated by Prime Minister Shigeru Ishiba the previous day.

He pledged to be “cautious and extremely sincere” when making the decision to sentence someone to death, according to Nippon Television’s online media.

Last week, 88-year-old Iwao Hakamada was found innocent of a quadruple murder he had spent 46 years on death row for.

A Japanese regional court ruled that investigators had tampered with the evidence and said Hakamada had been subject to “inhumane interrogations meant to force a statement”.

Hakamada is the fifth death row inmate granted a retrial in Japan’s post-war history. All four previous cases also resulted in exonerations.

The country’s last execution took place in July 2022, of a man who killed seven in a truck-ramming and stabbing rampage in Tokyo’s popular Akihabara electronics district in 2008.

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings